143 related articles for article (PubMed ID: 29460622)
1. Influence of UGT2B10 Genotype on Urinary Excretion of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol- N-glucuronide by African American Smokers.
Murphy SE; von Weymarn LB; Parenteau M; Stepanov I; Tiirikainen M; LeMarchand L; Park SL
Chem Res Toxicol; 2018 Mar; 31(3):168-175. PubMed ID: 29460622
[TBL] [Abstract][Full Text] [Related]
2. Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers.
Chen G; Luo S; Kozlovich S; Lazarus P
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1175-1184. PubMed ID: 27197298
[TBL] [Abstract][Full Text] [Related]
3. UGT1A and UGT2B genetic variation alters nicotine and nitrosamine glucuronidation in european and african american smokers.
Wassenaar CA; Conti DV; Das S; Chen P; Cook EH; Ratain MJ; Benowitz NL; Tyndale RF
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):94-104. PubMed ID: 25277794
[TBL] [Abstract][Full Text] [Related]
4. Role of l- and d-Menthol in the Glucuronidation and Detoxification of the Major Lung Carcinogen, NNAL.
Kozlovich S; Chen G; Watson CJW; Blot WJ; Lazarus P
Drug Metab Dispos; 2019 Dec; 47(12):1388-1396. PubMed ID: 31578206
[TBL] [Abstract][Full Text] [Related]
5. Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4.
Wiener D; Doerge DR; Fang JL; Upadhyaya P; Lazarus P
Drug Metab Dispos; 2004 Jan; 32(1):72-9. PubMed ID: 14709623
[TBL] [Abstract][Full Text] [Related]
6. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.
Derby KS; Cuthrell K; Caberto C; Carmella S; Murphy SE; Hecht SS; Le Marchand L
Int J Cancer; 2009 Nov; 125(10):2418-24. PubMed ID: 19598261
[TBL] [Abstract][Full Text] [Related]
7. Low Cotinine Glucuronidation Results in Higher Serum and Saliva Cotinine in African American Compared to White Smokers.
Murphy SE; Sipe CJ; Choi K; Raddatz LM; Koopmeiners JS; Donny EC; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1093-1099. PubMed ID: 28264876
[No Abstract] [Full Text] [Related]
8. Identification of a prevalent functional missense polymorphism in the UGT2B10 gene and its association with UGT2B10 inactivation against tobacco-specific nitrosamines.
Chen G; Dellinger RW; Gallagher CJ; Sun D; Lazarus P
Pharmacogenet Genomics; 2008 Mar; 18(3):181-91. PubMed ID: 18300939
[TBL] [Abstract][Full Text] [Related]
9. The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: sex-specific association with urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronidation phenotype and risk for lung cancer.
Gallagher CJ; Muscat JE; Hicks AN; Zheng Y; Dyer AM; Chase GA; Richie J; Lazarus P
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):823-8. PubMed ID: 17416778
[TBL] [Abstract][Full Text] [Related]
10. Variation in levels of the lung carcinogen NNAL and its glucuronides in the urine of cigarette smokers from five ethnic groups with differing risks for lung cancer.
Park SL; Carmella SG; Ming X; Vielguth E; Stram DO; Le Marchand L; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):561-9. PubMed ID: 25542827
[TBL] [Abstract][Full Text] [Related]
11.
Sipe CJ; Koopmeiners JS; Donny EC; Hatsukami DK; Murphy SE
Cancer Epidemiol Biomarkers Prev; 2020 Aug; 29(8):1673-1678. PubMed ID: 32532831
[TBL] [Abstract][Full Text] [Related]
12. Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups.
Murphy SE; Park SS; Thompson EF; Wilkens LR; Patel Y; Stram DO; Le Marchand L
Carcinogenesis; 2014 Nov; 35(11):2526-33. PubMed ID: 25233931
[TBL] [Abstract][Full Text] [Related]
13. Nicotine metabolism in African Americans and European Americans: variation in glucuronidation by ethnicity and UGT2B10 haplotype.
Berg JZ; Mason J; Boettcher AJ; Hatsukami DK; Murphy SE
J Pharmacol Exp Ther; 2010 Jan; 332(1):202-9. PubMed ID: 19786624
[TBL] [Abstract][Full Text] [Related]
14. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers.
Richie JP; Carmella SG; Muscat JE; Scott DG; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):783-90. PubMed ID: 9332760
[TBL] [Abstract][Full Text] [Related]
15. Correlation between UDP-glucuronosyltransferase genotypes and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone glucuronidation phenotype in human liver microsomes.
Wiener D; Fang JL; Dossett N; Lazarus P
Cancer Res; 2004 Feb; 64(3):1190-6. PubMed ID: 14871856
[TBL] [Abstract][Full Text] [Related]
16. Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine.
Carmella SG; Le Ka KA; Upadhyaya P; Hecht SS
Chem Res Toxicol; 2002 Apr; 15(4):545-50. PubMed ID: 11952341
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of nicotine and 4-(methylnitrosamino)-l-(3-pyridyl)-lbutanone (NNK) in menthol and non-menthol cigarette smokers.
Sarkar M; Wang J; Liang Q
Drug Metab Lett; 2012 Sep; 6(3):198-206. PubMed ID: 23140558
[TBL] [Abstract][Full Text] [Related]
18. Glucuronidation of tobacco-specific nitrosamines by UGT2B10.
Chen G; Dellinger RW; Sun D; Spratt TE; Lazarus P
Drug Metab Dispos; 2008 May; 36(5):824-30. PubMed ID: 18238858
[TBL] [Abstract][Full Text] [Related]
19. UGT2B10 genotype influences nicotine glucuronidation, oxidation, and consumption.
Berg JZ; von Weymarn LB; Thompson EA; Wickham KM; Weisensel NA; Hatsukami DK; Murphy SE
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1423-31. PubMed ID: 20501767
[TBL] [Abstract][Full Text] [Related]
20. Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphisms.
Chen G; Giambrone NE; Dluzen DF; Muscat JE; Berg A; Gallagher CJ; Lazarus P
Cancer Res; 2010 Oct; 70(19):7543-52. PubMed ID: 20876810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
